Company news

Medipost Co., Ltd. (KRX:078160) news

Medipost Co., Ltd. news releases on 6ix. Latest, May 14, 2026: Medipost's Cartistem® Meets All Primary And Secondary Endpoints In Japan Phase 3 Trial…

View Medipost Co., Ltd. →

Press releases & updates

Medipost's Cartistem® Meets All Primary And Secondary Endpoints In Japan Phase 3 Trial And Demonstrates Statistically Significant Efficacy Gains Versus Active Control

May 14, 2026

Medipost Inc. Submits Ind Amendment With U.S. Food And Drug Administration To Initiate Phase Iii Trial

February 13, 2026